Indegene Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Indegene Ltd is ₹ 571.5 as of 23 Oct 15:30 . The P/E Ratio of Indegene Ltd changed from 34 on March 2025 to 26 on March 2026 . This represents a CAGR of -12.55% over 2 yearsThe P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Indegene Ltd changed from ₹ 13878 crore on March 2025 to ₹ 10469 crore on March 2026 . This represents a CAGR of -13.14% over 2 yearsThe Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Indegene Ltd for the Jun '26 is ₹ 1092 crore as compare to the Mar '26 revenue of ₹ 1014 crore. This represent the growth of 7.68% The revenue of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Indegene Ltd for the Jun '26 is ₹ 203.2 crore as compare to the Mar '26 ebitda of ₹ 154.1 crore. This represent the growth of 31.86% The ebitda of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Indegene Ltd changed from ₹ 87.7 crore to ₹ 116.2 crore over 9 quarters. This represents a CAGR of 13.32% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Indegene Ltd changed from 26.42 % on March 2025 to 25.54 % on March 2026 . This represents a CAGR of -1.68% over 2 yearsThe Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Indegene Ltd

Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad.
Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016.
Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency.
As a specialized company, it combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.

About Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

FAQs for the comparison of Indegene Ltd and Lotus Eye Hospital & Institute Ltd

Which company has a larger market capitalization, Indegene Ltd or Lotus Eye Hospital & Institute Ltd?

Market cap of Indegene Ltd is 13,768 Cr while Market cap of Lotus Eye Hospital & Institute Ltd is 234 Cr

What are the key factors driving the stock performance of Indegene Ltd and Lotus Eye Hospital & Institute Ltd?

The stock performance of Indegene Ltd and Lotus Eye Hospital & Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indegene Ltd and Lotus Eye Hospital & Institute Ltd?

As of October 25, 2026, the Indegene Ltd stock price is INR ₹571.5. On the other hand, Lotus Eye Hospital & Institute Ltd stock price is INR ₹112.75.

How do dividend payouts of Indegene Ltd and Lotus Eye Hospital & Institute Ltd compare?

To compare the dividend payouts of Indegene Ltd and Lotus Eye Hospital & Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.